Yi-ping Li
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c.
Journal: Antimicrobial agents and chemotherapy
Published: September 18, 2019
Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
Journal: Virology
Published: March 04, 2018
HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.
Journal: Gastroenterology
Published: September 20, 2017
Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
Journal: Antimicrobial agents and chemotherapy
Published: January 21, 2017
Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir.
Journal: The Journal of general virology
Published: March 04, 2016
Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle.
Journal: Antimicrobial agents and chemotherapy
Published: December 07, 2015
Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: August 13, 2015
Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
Journal: Journal of virology
Published: October 31, 2014
An oligonucleotide-tagged microarray for routine diagnostics of colon cancer by genotyping KRAS mutations.
Journal: International journal of oncology
Published: January 20, 2014
Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.
Journal: Hepatology (Baltimore, Md.)
Published: June 12, 2013
Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses.
Journal: Antimicrobial agents and chemotherapy
Published: January 01, 2013
Last Updated: 09/26/2026